| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
14,410,000 |
| Market
Cap: |
4.80(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.3333 - $0.3333 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Diagnostic Substances |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
183,171 |
| Total Buy Value |
$0 |
$0 |
$0 |
$421,674 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
8 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ma-Weaver Jacob |
See Footnote 1 |
– – – |
2022-04-14 |
4 |
B |
$2.33 |
$40,546 |
D/D |
17,410 |
2,171,100 |
2.44 |
- |
|
| Ma-Weaver Jacob |
See Footnote 1 |
– – – |
2022-04-12 |
4 |
B |
$2.32 |
$161,101 |
D/D |
69,398 |
2,153,690 |
2.44 |
- |
|
| Ma-Weaver Jacob |
See Footnote 1 |
– – – |
2022-04-11 |
4 |
B |
$2.32 |
$10,776 |
D/D |
4,655 |
2,084,292 |
2.44 |
- |
|
| Ma-Weaver Jacob |
See Footnote 1 |
– – – |
2022-04-08 |
4 |
B |
$2.31 |
$70,852 |
D/D |
30,660 |
2,079,637 |
2.44 |
- |
|
| Ma-Weaver Jacob |
See Footnote 1 |
– – – |
2022-04-07 |
4 |
B |
$2.32 |
$63,706 |
D/D |
27,450 |
2,048,977 |
2.44 |
- |
|
| Ma-Weaver Jacob |
See Footnote 1 |
– – – |
2022-04-06 |
4 |
B |
$2.30 |
$61,603 |
D/D |
26,806 |
2,021,527 |
2.44 |
- |
|
| Ma-Weaver Jacob |
See Footnote 1 |
– – – |
2022-04-05 |
4 |
B |
$2.30 |
$114,469 |
D/D |
49,728 |
1,994,721 |
2.44 |
- |
|
| Ma-Weaver Jacob |
See Remarks |
– – – |
2022-04-04 |
4/A |
B |
$2.26 |
$276,309 |
D/D |
122,342 |
1,944,993 |
2.44 |
- |
|
| Funicular Fund, Lp |
See Footnote 1 |
– – – |
2022-04-04 |
4 |
B |
$2.26 |
$276,309 |
D/D |
122,342 |
1,944,993 |
2.44 |
- |
|
| Ma-Weaver Jacob |
|
– – – |
2022-04-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
1,822,651 |
|
- |
|
| Funicular Fund, Lp |
|
– – – |
2022-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,822,651 |
|
- |
|
| Conway Robert |
Chairman of the Board |
– • – |
2021-05-12 |
4 |
B |
$3.19 |
$31,947 |
D/D |
10,000 |
50,000 |
2.39 |
- |
|
| Conway Robert |
Chairman of the Board |
– • – |
2021-05-05 |
4 |
B |
$3.23 |
$32,345 |
D/D |
10,000 |
40,000 |
2.39 |
- |
|
| Conway Robert |
Chairman of the Board |
– • – |
2020-12-18 |
4 |
B |
$4.16 |
$41,630 |
D/D |
10,000 |
30,000 |
2.39 |
- |
|
| Conway Robert |
Chairman of the Board |
– • – |
2020-09-25 |
4 |
B |
$4.28 |
$21,400 |
D/D |
5,000 |
20,000 |
2.39 |
- |
|
| Conway Robert |
Chairman of the Board |
– • – |
2020-09-22 |
4 |
B |
$4.66 |
$14,241 |
D/D |
3,056 |
15,000 |
2.39 |
- |
|
| Conway Robert |
Chairman of the Board |
– • – |
2020-09-21 |
4 |
B |
$4.77 |
$47,660 |
D/D |
10,000 |
11,944 |
2.39 |
- |
|
| Keuer Thomas A |
Chief Operating Officer |
• – – |
2018-04-03 |
4 |
AS |
$0.50 |
$242 |
D/D |
(482) |
13,153 |
|
- |
|
| Selby Brian L. |
VP, Finance |
• – – |
2018-04-02 |
4 |
AS |
$0.50 |
$556 |
D/D |
(1,114) |
0 |
|
- |
|
| Keuer Thomas A |
Chief Operating Officer |
• – – |
2018-02-28 |
4 |
AS |
$0.72 |
$294 |
D/D |
(410) |
13,635 |
|
- |
|
| Selby Brian L. |
VP, Finance |
• – – |
2018-02-27 |
4 |
AS |
$0.53 |
$85 |
D/D |
(161) |
1,114 |
|
- |
|
| Barris Peter J |
10% Owner |
– – • |
2018-02-26 |
4 |
S |
$0.50 |
$731,273 |
I/I |
(1,460,209) |
0 |
|
- |
|
| Nea 15 Gp, Llc |
10% Owner |
– – • |
2018-02-26 |
4 |
S |
$0.50 |
$731,273 |
D/D |
(1,460,209) |
0 |
|
- |
|
| Florence Anthony A. Jr. |
10% Owner |
– – • |
2018-02-26 |
4 |
S |
$0.50 |
$731,273 |
I/I |
(1,460,209) |
0 |
|
- |
|
| Sandell Scott D |
10% Owner |
– – • |
2018-02-26 |
4 |
S |
$0.50 |
$731,273 |
I/I |
(1,460,209) |
0 |
|
- |
|
115 Records found
|
|
Page 2 of 5 |
|
|
